Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.575
+0.015 (0.96%)
At close: May 17, 2024, 4:00 PM
1.650
+0.075 (4.76%)
After-hours: May 17, 2024, 5:21 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $180.06 million as of May 17, 2024. Its market cap has increased by 34.17% in one year.
Market Cap
180.06M
Enterprise Value
229.74M
1-Year Change
34.17%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $180.06M, a decrease of -61.90%. That is a compound annual growth rate of -23.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 180.60M | 0.95% |
| May 16, 2024 | 178.90M | 2.29% |
| May 15, 2024 | 174.90M | 1.98% |
| May 14, 2024 | 171.50M | -1.61% |
| May 13, 2024 | 174.30M | -3.81% |
| May 10, 2024 | 181.20M | 1.91% |
| May 9, 2024 | 177.80M | - |
| May 8, 2024 | 177.80M | 18.30% |
| May 7, 2024 | 150.30M | 1.97% |
| May 6, 2024 | 147.40M | 8.62% |
| May 3, 2024 | 135.70M | 6.85% |
| May 2, 2024 | 127.00M | 4.79% |
| May 1, 2024 | 121.20M | 0.83% |
| Apr 30, 2024 | 120.20M | 1.61% |
| Apr 29, 2024 | 118.30M | -1.17% |
| Apr 26, 2024 | 119.70M | -1.97% |
| Apr 25, 2024 | 122.10M | - |
| Apr 24, 2024 | 122.10M | -1.61% |
| Apr 23, 2024 | 124.10M | -0.80% |
| Apr 22, 2024 | 125.10M | 3.22% |
| Apr 19, 2024 | 121.20M | - |
| Apr 18, 2024 | 121.20M | 3.32% |
| Apr 17, 2024 | 117.30M | -3.22% |
| Apr 16, 2024 | 121.20M | - |
| Apr 15, 2024 | 121.20M | 1.68% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OptiNose | 183.95M |
| Abeona Therapeutics | 183.28M |
| Greenwich LifeSciences | 182.74M |
| Outlook Therapeutics | 181.51M |
| Orchestra BioMed Holdings | 180.73M |
| CVRx, Inc. | 179.24M |
| Telomir Pharmaceuticals | 179.14M |
| Lifecore Biomedical | 177.63M |